Administration of Recombinant Activated Factor VII (NovoSeven) in Three Cases of Uncontrolled Bleeding Caused by Disseminated Intravascular Coagulopathy

Abstract

Recombinant activated factor VII has been used successfully in many cases of traumatic and surgical bleeding complications that were unresponsive to standard treatment. However, because disseminated intravascular coagulation can develop from a thrombin burst as a side effect of recombinant activated factor VII, it is not yet established for bleeding complications induced by disseminated intravascular coagulation. This article presents 3 patients with severe sepsis and fulminant disseminated intravascular coagulation. Excessive microvascular bleeding persisted despite conventional therapy, and surgical intervention and radiologic embolization did not control bleeding. After administration of recombinant activated factor VII, bleeding ceased in all patients, and no overt thromboembolic events occurred. One patient survived to be discharged from the hospital. The other 2 patients died from refractory multiorgan failure and overall poor prognosis. Recombinant factor VIIa might be an option for the treatment of severe bleeding complications in the case of DIC refractory to the conventional therapy.

Keywords

rFVIIa Disseminated intravascular coagulopathy Disseminated intravascular coagulation Bleeding.

References

Hambleton J. , Leung LL , Levi M. Coagulation: consultive hemostasis. Hematology Am Soc Hematol Educ Program. 2002: 335-352.

Taylor FB Jr, Toh CH , Hoots WK , et al. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327-1330.

DeSancho MT , Rand JH Bleeding and thrombotic complications in critically ill patients with cancer . Crit Care Clin. 2001;17:599-622.

Alving BM , Spivak JL , DeLoughery TG Consultative hematology: hemostasis and transfusion issues in surgery and critical care medicine. In: McArthur JR , Schechter GP , Schrier SL , eds. Hematology 1998: The American Society of Hematology Education Program Book. Washington, DC: American Society of Hematology; 1998:320-341.

Lynn M. , Jeroukhimov I. , Klein Y. , Martinowitz U. Updates in management of severe coagulopathy in trauma patients. Intensive Care Med. 2002;28(suppl 2):241-247.

Silva MA , Muralidharan V. , Mirza DF The management of coagulopathy and blood loss in liver sugery. Semin Hematol. 2004;(suppl 1):132-139.

Haas T. , Innerhofer P. , Kühbacher G. , Fries D. Successful reversal of deleterious coagulopathy by recombinant factor VIIa . Anesth Analg. 2005;100:54-58.

Gerotziafas GT , Zervas K. , Arzoglou P. , et al. On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation. Br J Haematol. 2002;117:705-708.

Roberts HR , Monroe DM , Hoffmman M. Safety profile of recombinant factor VIIa. Semin Hematol. 2004;41(suppl 1): 101-108.

10.

Negrier C. , Lienhart A. Overall experience with NovoSeven. Blood Coagul Fibrinolysis. 2000;11:19-24.

11.

Gando S. Disseminated intravascular coagulation in trauma patients. Semin Thromb Hemost. 2001;27:585-592.

12.

Dempfle CE Coagulopathy of sepsis. Thromb Hemost. 2004 ;91:213-224.

13.

Levi M. , de Jonge E. , van der Poll T. , ten Cate H. Advances in the understanding of the pathogenic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies. Semin Thromb Hemost. 2001;27:569-575.

14.

Mammen EF Disseminated intravascular coagulation (DIC). Clin Lab Sci. 2000;13:239-245.

15.

Stanworth S. , Brunskill S. , Hyde CJ , McClelland D. , Murphy M. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol. 2004;126:139-152.

16.

Chowdhury P. , Saayman A. , Paulus U. , Findlay G. , Collins P. Efficacy of standard dose and 30 mL/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol. 2004;125:69-73.

17.

Sallah S. , Husain A. , Nguyen NP Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation. Blood Coagul Fibrinolysis. 2004;15:577-582.

18.

Moscardo F. , Perez F. , De La Rubia J. , et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol. 2001;113:174-176.

19.

Cid AR , Martinez J. , Aznart JA , et al. Treatment with recombinant activated factor VIIa of intraabdominal bleeding associated with disseminated intravascular coagulation caused by septic shock. Presented at: the XIX Congress of the International Society of Thrombosis and Haemostasis 2003 , Birmingham, UK.